key: cord-0688650-c2jy4qde
authors: Daly, Michael; Robinson, Eric
title: Willingness to Vaccinate Against COVID-19 in the U.S.: Representative Longitudinal Evidence From April to October 2020
date: 2021-02-15
journal: Am J Prev Med
DOI: 10.1016/j.amepre.2021.01.008
sha: 2d2db51185c82748d236298afb7d6e5d25a793f3
doc_id: 688650
cord_uid: c2jy4qde

Introduction Vaccines against coronavirus disease (COVID-19) have been developed in unprecedented time. However, the effectiveness of any vaccine is dictated by the proportion of the population willing to be vaccinated. This observational population-based study examines intentions to be vaccinated against COVID-19 throughout the pandemic. Methods In November 2020, longitudinal data from a nationally representative sample of 7,547 U.S. adults enrolled in the Understanding America Study were analyzed using multinomial logistic regression. Participants reporting being willing, undecided, and unwilling to get vaccinated against COVID-19 across 13 assessments conducted from April to October 2020. Public attitudes to vaccination against COVID-19 were also assessed on a 4-point Likert scale. Results Willingness to vaccinate declined from 71% in April to 53.6% in October. This was explained by an increase in the percentage of participants undecided about vaccinating (from 10.5% to 14.4%) and the portion of the sample unwilling to vaccinate (from 18.5% to 32%). The population subgroups most likely to be undecided/unwilling to vaccinate were those without a degree (undecided: RRR=2.47, 95% CI=2.04, 3.00; unwilling: RRR=1.92, 95% CI=1.67, 2.20), Black participants (undecided: RRR=2.18, 95% CI=1.73, 2.74; unwilling: RRR=1.98, 95% CI=1.63, 2.42), and female participants (undecided: RRR=1.41, 95% CI=1.20, 1.65; unwilling: RRR=1.29, 95% CI=1.14, 1.46). Participants who were older or were on higher incomes were least likely to be undecided or unwilling to vaccinate. Concerns about potential side effects of a vaccine were common. Conclusions Intentions to be vaccinated against COVID-19 have declined rapidly during the pandemic and close to half of Americans are undecided or unwilling to be vaccinated.

As of mid-February 2021, the coronavirus disease 2019 (COVID- 19) pandemic has been responsible for >2.3 million deaths worldwide. 1 Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed in unprecedented time and there are now multiple vaccines that have been shown to be effective in preventing symptomatic COVID-19 infections. 2 The U.S. Food and Drug Administration has issued emergency use authorization for mass roll out of the Pfizer-BioNTech and Moderna COVID-19 vaccines 3 and other candidates may be approved for distribution in the near future.

However, the overall effectiveness of any vaccine is dictated, at least in part, by the proportion of the population willing to be vaccinated. Simulation studies suggest at least three quarters of the population may need to be vaccinated to extinguish the ongoing COVID-19 pandemic. 4, 5 During the early stages of the pandemic (March-June), studies of small samples of European and Australian adults suggested that the majority of surveyed people reported that they would be vaccinated when a widely available vaccine was available. 6, 7 Similarly, a nationally representative study of adults in China conducted in March found that 9 in 10 would accept a vaccine when available. 8 U.S. studies conducted early in the pandemic found that between 58% and 86% of adults reported they were likely to be vaccinated against COVID-19. 6, [9] [10] [11] However, the rise of "fake news" during the pandemic has been widely acknowledged 11, 12 and widespread misinformation about the pandemic may have been damaging to public uptake of measures designed to reduce the spread of the virus (e.g., mask wearing, social distancing) and willingness to vaccinate. 10, 13, 14 In addition, because the speed at which coronavirus vaccines have been developed has been unparalleled and this has been widely reported, 2,3 this may have made the general public more hesitant about accepting a vaccine when available. 15, 16 Furthermore, research indicates that in some countries public trust in government handling of the COVID-19 crisis has been affected negatively 17 and this too may have detrimentally affected intentions to follow public health guidance.

The COVID-19 pandemic has had a disproportionately large impact on ethnic minorities 18 and groups from lower socioeconomic backgrounds, 19 and as infections will likely continue to be socially patterned, understanding whether population demographics determine willingness to vaccinate will also be important. For example, research examining previous influenza vaccination programs has found that vaccination intentions and uptake are reduced among more disadvantaged groups. 20, 21 Initial research examining COVID-19 vaccination intentions has produced mixed findings on the role of demographic predictors, which may be due to a reliance to date on relatively small and non-representative samples. 9, 10, 22 The current study examines estimates of the proportion of the U.S. general population that would be willing to use a vaccine when available. In addition, this study examines whether estimates of vaccination uptake collected much earlier in the pandemic have changed over time. Further, this study seeks to understand whether intentions to vaccinate are socially patterned and more or less likely in specific population subgroups. This information will provide an empirical basis for directing public health messages at those who are least likely to vaccinate. 15, 16 To do this, this research made use of data from the Understanding America Study (UAS), a large nationally representative panel of U.S. adults who have reported their vaccine intentions on 13 occasions from the outbreak of the pandemic through October 2020.

This study utilized data collected as part of the UAS, a nationally representative longitudinal study of adults aged ≥18 years. The UAS is a probability-based sample recruited via addressbased sampling from the U.S. Postal Service Computerized Delivery Sequence file containing all U.S. postal addresses. 23 Participants complete surveys online and those without Internet access are provided with tablet computers and Internet access. Surveys were administered in English and Spanish and participants were compensated approximately $20 for 30 minutes of survey time. 24 Of 8,547 UAS participants eligible to take part in the COVID-19 tracking study, 7,547 participated and provided data. The UAS COVID-19 tracking study has been utilized to examine changes in personal and social reactions, risk perception, 25, 26 and mental health 27 in response to the pandemic. Vaccination intentions were assessed in 13 of the 15 waves of assessment conducted every 2 weeks between April 1 and October 31, 2020. 24 The number of participants and observations per survey month are shown in Appendix Table 1 . The percentage of participants providing willingness to vaccinate data was lowest in June (74.1%) and relatively stable in other months (ranging from 81.8% to 88.1%) (Appendix Table 1 ).

In total, participants provided 80,060 observations across the 13 survey waves (average response rate of 81.6% among COVID tracking study participants). A small portion (2%) of observations were omitted because they were submitted after October 31 or were missing vaccination intentions or covariate data, leaving a total of 78,453 observations (10.4 per participant). The UAS weights were applied to adjust for unequal probabilities of selection into the UAS. Post-stratification weights were also incorporated to provide a correction for non-response by aligning each survey wave with the distribution of demographic characteristics of the U.S. population. 28 The UAS was approved by the University of Southern California human subjects committee IRB and informed consent was obtained from all subjects (via computer link). The Maynooth University Social Research Ethics Sub-Committee does not require ethical approval to be granted for the secondary use of anonymous data such as the data used in the current study. Vaccination intentions were predicted by month of survey (April, May, June, July, August, September, October) and a set of demographic variables: age (18-34, 35-44, 50-64, ≥65 years), sex (male, female), race/ethnicity (White, Hispanic, Black, other race/ethnicity), household income (≤$40,00/$40,000-$100,000/≥$100,000 gross per annum), college degree (versus none), and the presence of a chronic health condition (present versus not present).

Specifically, participants indicated whether they had been diagnosed with the following conditions: diabetes, cancer, heart disease, kidney disease, asthma, chronic lung disease, or an autoimmune disease.

Participants also reported their level of agreement (from 1=strongly disagree to 4=strongly agree) with 9 items assessing their attitudes toward a potential vaccine (Table 3 provides items in full) in late October (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) (31) . Questions assessed participant beliefs that the COVID-19 vaccine would be beneficial, important for personal and community health, and a good way to protect from COVID-19. Participants also indicated whether they agreed approved vaccines would be effective and whether they were concerned about the lack of long-term follow-up information and potential side effect of a COVID-19 vaccine were assessed (e.g., I think the COVID-19 vaccine might cause lasting health problems for me).

First, investigators examined trends in vaccinate intentions over the period of the study by comparing the prevalence of willingness/being undecided/unwillingness to vaccinate in April and October 2020. To estimate the statistical significance of time trends, multinomial logistic regression analysis 29 Table 2 ). Unadjusted multinomial logistic regression analyses also showed that all population subgroups were more likely to be undecided or unwilling to vaccinate in October compared with April (Appendix Table 2 ). There was also an >2-fold higher relative likelihood of being undecided or unwilling to get the COVID-19 vaccine in October compared with April 2020 (undecided: RRR=2.03, 95% CI=1.79, 2.29; unwilling: RRR=2.47, 95% CI=2.27, 2.68) in a fully adjusted model that included controls for participant demographic factors and the presence of chronic illness (Table 2 ). An examination of month-to-month changes confirmed that the likelihood of being undecided or unwilling to vaccinate (versus being willing to vaccinate) increased from April to October ( An examination of the interactions between survey month and individual demographic characteristics did not yield evidence for systematic differences in changes in vaccination intentions over time between demographic groups. Further, very similar associations were identified in a sensitivity analysis where willingness to vaccinate was treated as a continuous variable (Appendix Table 3 ).

Finally, this study examined attitudes toward the vaccine reported between October 14 and 31, 2020. The majority of the sample (70%-80%) agreed that the COVID-19 vaccine would be personally beneficial, important for personal and community health, a good way to protect from COVID-19, and effective if approved by the U.S. Food and Drug Administration or the Centers for Disease Control and Prevention (Table 3) . However, responses differed markedly between those willing and unwilling to be vaccinated. For example, whereas 92.4% of those who were willing to be vaccinated agreed that the vaccine would be effective if approved by the Food and Drug Administration or Centers for Disease Control and Prevention, only 43.1% of those unwilling to be vaccinated agreed. In the overall sample, it was common for participants to report concerns over the vaccine and 69.7% agreed they were concerned about serious side effects of the vaccine. Forty-four percent agreed the vaccine might cause lasting health problems for them. However, such concerns were more prevalent among those unwilling to be vaccinated. For example, 65% of those unwilling to be vaccinated were concerned about lasting health problems resulting from the vaccine compared with 26.6% of those willing to be vaccinated.

In a large nationally representative sample of U.S. adults, intentions to be vaccinated against COVID-19 have declined from a high of 71% of the population in April to close to only 54%

reporting being willing to vaccinate in October 2020. Reporting being undecided or unwilling to vaccinate was more likely among those with lower levels of education and income, as well as female, Black (African American), and younger adults. Concerns about the vaccine causing long lasting health problems and uncertainty about the benefits of the vaccine were also common.

Based on estimates that vaccination coverage of close to 75% may be required to vaccinate to eradicate COVID-19, 4,5,10,30 the present estimates that close to 50% of the population may be willing to vaccinate are concerning. It will now be critical to better understand the reasons why a large proportion of the population are skeptical about vaccination against COVID-19.

Public concerns about the safety of vaccines may be an important driver of the increase in the proportion of the population reporting being unsure or explicitly stating they will not vaccinate. 10 In line with this, 70% of the present sample reported being concerned about serious side effects of the vaccine and 44% believed that a vaccine might cause lasting health problems for them. To some extent, these concerns are to be expected given the unprecedented speed at which vaccines have been developed. 2, 3 However, the rise of anti-vaccination misinformation (e.g., misleading healthcare information, conspiracy theories) and political polarization may also have played a role in explaining this increase. [11] [12] [13] [14] 30 It will therefore be critical that accurate safety information is widely and transparently communicated by trusted sources to promote confidence in the scientific decision making underpinning the approval of COVID-19 vaccines. 16, 21 It will also be important to address social inequalities in vaccination intentions, 20, 21 and to ensure widespread uptake of effective COVID-19 vaccines. In the present study, willingness to vaccinate was strikingly lower among more disadvantaged groups (e.g., African

Americans, those with lower income and education levels) and these groups have already been disproportionately affected by COVID-19. 18, 19 Previous research on influenza vaccines also suggests that access issues may prevent minority and disadvantaged groups from being vaccinated. 21, 31 It will therefore be important to identify strategies to reduce social inequalities in both vaccination intentions and opportunities to vaccinate. 20 Strengths of the present research include the use of a large probability-based nationally representative sample of adults allowing generalizations to be made to the population. The current study also moves beyond prior research 6-10 by including a high-frequency longitudinal assessment of vaccination intentions throughout the pandemic. In addition, participant concerns and perceptions of the benefits of a potential vaccine were assessed to shed light on potential reasons for low willingness to vaccinate.

A limitation of the UAS is the potential lack of representation of those who do not speak either English or Spanish and those not comfortable engaging with online surveys. In addition, this study is limited in its reliance on self-reported intentions about a hypothetical vaccine and the lack of detailed assessment of factors that may explain why vaccination intentions have declined over time in the U.S. However, in advance of the deployment of a COVID-19 vaccine, it has been necessary to rely on intention-based measures that have been shown to predict vaccination behavior. 31 Further, intentions are malleable and represent a target for evidence-based approaches aiming to increase the proportion of the population that are willing to vaccinate. 32 This now represents an urgent public health priority to minimize further loss of life due to the COVID-19 pandemic. 33 It is also essential that research aiming to modify vaccination uptake is theory-based and informed by relevant models such as the Health Belief Model, 34 which provides a framework for understanding factors that may shape vaccination intentions (e.g., perceived benefits and barriers, perceived susceptibility to COVID-19) and future behavior.

Finally, now that vaccines are authorized and information on their effectiveness and safety is available, it is crucial that studies track vaccination attitudes (e.g., perceived health benefits and side effects, social norms relating to vaccination) to provide an in-depth understanding of how vaccine intentions and uptake change as vaccines are deployed. Initial research suggests that willingness to vaccinate may have increased in November as the availability of viable vaccines appeared imminent. 35 

Intentions to be vaccinated against COVID-19 have declined rapidly during the pandemic and in October 2020, close to half of Americans were undecided or unwilling to be vaccinated.

This reduced willingness to vaccinate may undermine the pandemic response and the public health benefits of an effective vaccine. Boldface indicates statistical significance (*p<0.05; **p<0.01; ***p<0.001). a Estimates are relative risk ratios derived from multinomial logistic regression with SEs adjusted for clustering at the individual-level and controlling for all characteristics presented. For all analyses "willing to vaccinate" was the outcome reference group. b Households earning less than $40,000 a year classified as low income, those earning $40,000-$100,000 middle income, and those above this threshold as high-income. c Diagnosed with any of the following: diabetes, cancer, heart disease, kidney disease, asthma, chronic lung disease, an autoimmune disease. 

WHO COVID-19 Weekly Epidemiological Update

Developing Covid-19 vaccines at pandemic speed

FDA takes additional action in fight against COVID-19 by issuing Emergency Use Authorization for second COVID-19 vaccine

Vaccine efficacy needed for a COVID-19 coronavirus vaccine to prevent or stop an epidemic as the sole intervention

Will an imperfect vaccine curtail the COVID-19 pandemic in the

A global survey of potential acceptance of a COVID-19 vaccine

Willingness to vaccinate against COVID-19 in Australia

Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China

A proactive approach for managing COVID-19: the importance of understanding the motivational roots of vaccination hesitancy for SARS-CoV2

Attitudes toward a potential SARS-CoV-2 vaccine: a survey of U.S. adults

Conspiracy theories as barriers to controlling the spread of COVID-19 in the US

A postmodern Pandora's box: anti-vaccination misinformation on the Internet

Susceptibility to misinformation about COVID-19 around the world

Polarization and public health: partisan differences in social distancing during the coronavirus pandemic

Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19

Reassuring the public and clinical community about the scientific review and approval of a COVID-19 vaccine

The Cummings effect: politics, trust, and behaviours during the COVID-19 pandemic

Outcomes of COVID-19: disparities in obesity and by ethnicity/race

Differential COVID-19 case positivity in New York City neighborhoods: socioeconomic factors and mobility. Influenza Other Respir Viruses

Influenza vaccination uptake and socioeconomic determinants in 11 European countries

Socioeconomic status, demographics, beliefs and A (H1N1) vaccine uptake in the United States

Acceptability of a COVID-19 vaccine among adults in the United States: how many people would get vaccinated? Vaccine

An introduction to the Understanding America Study internet panel

Tracking the effect of the COVID-19 pandemic on the lives of American households

How does age affect personal and social reactions to COVID-19: results from the national Understanding America Study

Psychological distress and adaptation to the COVID-19 crisis in the United States

Explaining the rise and fall of psychological distress during the COVID-19 crisis in the US: Longitudinal evidence from the Understanding America Study. Br J Health Psychol

Sampling and weighting the Understanding America Study

Logistic regression using SAS: Theory and application. SAS Institute

Rapid review: COVID-19 vaccine deployment: Behaviour, ethics, misinformation and policy strategies

Barriers of influenza vaccination intention and behavior-a systematic review of influenza vaccine hesitancy

Overcoming the knowledgebehavior gap: the effect of evidence-based HPV vaccination leaflets on understanding, intention, and actual vaccination decision

Anti-vaccine attitudes and risk factors for not agreeing to vaccination against COVID-19 amongst 32,361 UK adults: implications for public health communications

The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay

Intent to get a COVID-19 vaccine rises to 60% as confidence in research and development process increases